Work in the Klengel Lab focuses on the underlying molecular mechanisms of neuropsychiatric diseases and towards the development of novel preventive and therapeutic approaches.

Psychiatric disorders are highly prevalent; yet, our understanding of the underlying molecular mechanisms leading to the development of these devastating disorders is unfortunately scarce. As a consequence, we also currently lack effective preventive and therapeutic strategies, which leads to an enormous burden for individuals, families, and our societies. The goal of our group is to contribute to a better understanding of psychiatric diseases and thus better interventions. Pursuing a translational approach, we integrate clinically derived data sets and samples, animal models and a diverse set of molecular approaches to identify factors contributing on the molecular level to risk or resilience for psychiatric diseases.